From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)

References

• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420:1–10.
   PubMed Web of Science ®Google Scholar
• Jain S, Patel N, Lin S. Solubility and dissolution enhancement strategies: current understanding and recent trends. Drug Dev Ind Pharm. 2015;41:875–887.
   PubMed Web of Science ®Google Scholar
• McClements DJ. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter. 2012;8:1719–1729.
   Web of Science ®Google Scholar
• Date AA, Desai N, Dixit R, et al. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine. 2010;5:1595–1616.
   PubMed Web of Science ®Google Scholar
• Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp. 2011;392:145–155.
   Web of Science ®Google Scholar
• Fong SYK, Martins SM, Brandl M, et al. Solid phospholipid dispersions for oral delivery of poorly soluble drugs: investigation into celecoxib incorporation and solubility-in vitro permeability enhancement. J Pharm Sci. 2016;105:1113–1123.
   PubMed Web of Science ®Google Scholar
• Lee H, Lee J. Dissolution enhancement of celecoxib via polymer-induced crystallization. J Cryst Growth. 2013;374:37–42.
   Web of Science ®Google Scholar
• Gidwani B, Vyas A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015;2015. Article ID 198268. doi:10.1155/2015/198268
   PubMed Web of Science ®Google Scholar
• Chen J, Mosquera-Giraldo LI, Ormes JD, et al. Bile salts as crystallization inhibitors of supersaturated solutions of poorly water-soluble compounds. Cryst Growth Des. 2015;15:2593–2597.
   Web of Science ®Google Scholar
• Gaba B, Fazil M, Ali A, et al. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration. Drug Deliv. 2015;22:691–700.
   PubMed Web of Science ®Google Scholar
• Gautam SP, Gupta AK, Wani SUD, et al. PAMAM dendrimers mediated solubility enhancement of poorly soluble drugs: a concise review. Int J Pharma Drug Anal. 2015;3:105–110.
   Google Scholar
• Čerpnjak K, Zvonar A, Gašperlin M, et al. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63:427–445.
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–637.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’drug delivery systems. Eur J Pharm Sci. 2000;11:S93–S98.
   PubMed Web of Science ®Google Scholar
• Brüsewitz C, Schendler A, Funke A, et al. Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int J Pharm. 2007;329:173–181.
   PubMed Web of Science ®Google Scholar
• Seeballuck F, Lawless E, Ashford MB, et al. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model. Pharm Res. 2004;21:2320–2326.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231–248.
   PubMed Web of Science ®Google Scholar
• Subramanian R, Wasan KM. Effect of lipid excipients on in vitro pancreatic lipase activity. Drug Dev Ind Pharm. 2003;29:885–890.
   PubMed Web of Science ®Google Scholar
• Mohsin K, Shahba A, Alanazi F. Lipid based self emulsifying formulations for poorly water soluble drugs-an excellent opportunity. Indian J Pharm Educ Res. 2012;46:88–196.
   Web of Science ®Google Scholar
• Ren S, Park M-J, Kim A, et al. In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients. Arch Pharm Res. 2008;31:406–413.
   PubMed Web of Science ®Google Scholar
• Vemula RB. Lipid based self-emulsifying drug delivery system (SEDDS) for poorly water-soluble drugs: A review. J Global Pharma Technol. 2010;2.
   Google Scholar
• Chime SA, Onyishi IV. Lipid-based drug delivery systems (LDDS): recent advances and applications of lipids in drug delivery. Afr J Pharm Pharmacol. 2013;7:3034–3059.
   Google Scholar
• Wadhwa J, Nair A, Kumria R. Emulsion forming drug delivery system for lipophilic drugs. Acta Pol Pharm. 2012;69:179–191.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Gu F, Zhang L, et al. Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther. 2008;8:1063–1070.
   PubMed Web of Science ®Google Scholar
• Pathak K, Raghuvanshi S. Oral bioavailability: issues and solutions via nanoformulations. Clin Pharmacokinet. 2015;54:325–357.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu F, Chan J, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:761–769.
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26:523–580.
   PubMed Web of Science ®Google Scholar
• Alonso MJ. Nanomedicines for overcoming biological barriers. Biomed Pharmacother. 2004;58:168–172.
   PubMed Web of Science ®Google Scholar
• Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed Nanotechnol Biol Med. 2010;6:9–24.
   PubMed Web of Science ®Google Scholar
• Alaouie AM, Sofou S. Liposomes with triggered content release for cancer therapy. J Biomed Nanotechnol. 2008;4:234–244.
   Web of Science ®Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85:427–443.
   PubMed Web of Science ®Google Scholar
• Boyd BJ. Past and future evolution in colloidal drug delivery systems. Expert Opin Drug Deliv. 2008;5:69–85.
   PubMed Web of Science ®Google Scholar
• Solans C, Izquierdo P, Nolla J, et al. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10:102–110.
   Web of Science ®Google Scholar
• Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res. 2011;28:978–985.
   PubMed Web of Science ®Google Scholar
• Tadros T, Izquierdo P, Esquena J, et al. Formation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108:303–318.
   PubMed Web of Science ®Google Scholar
• Gutiérrez J, González C, Maestro A, et al. Nano-emulsions: new applications and optimization of their preparation. Curr Opin Colloid Interface Sci. 2008;13:245–251.
   Web of Science ®Google Scholar
• Constantinides PP, Chaubal MV, Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev. 2008;60:757–767.
   PubMed Web of Science ®Google Scholar
• Anton N, Vandamme TF. The universality of low-energy nano-emulsification. Int J Pharm. 2009;377:142–147.
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit J-P, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates—a review. J Control Release. 2008;128:185–199.
   PubMed Web of Science ®Google Scholar
• Bates TR, Carrigan PJ. Apparent absorption kinetics of micronized griseofulvin after its oral administration on single‐and multiple‐dose regimens to rats as a corn oil‐in‐water emulsion and aqueous suspension. J Pharm Sci. 1975;64:1475–1481.
   PubMed Web of Science ®Google Scholar
• Anwer MK, Jamil S, Ibnouf EO, et al. Enhanced antibacterial effects of clove essential oil by nanoemulsion. J Oleo Sci. 2014;63:347–354.
   PubMed Web of Science ®Google Scholar
• Sonneville-Aubrun O, Simonnet J-T, L’alloret F. Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci. 2004;108:145–149.
   PubMed Web of Science ®Google Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227–243.
   PubMed Web of Science ®Google Scholar
• Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech. 2007;8:E12–E17.
   PubMed Web of Science ®Google Scholar
• Gorain B, Choudhury H, Kundu A, et al. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces. 2014;115:286–294.
   PubMed Web of Science ®Google Scholar
• Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76:410–420.
   PubMed Web of Science ®Google Scholar
• Puglia C, Rizza L, Drechsler M, et al. Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation. Drug Deliv. 2010;17:123–129.
   PubMed Web of Science ®Google Scholar
• Singh S, Pathak K, Bali V. Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form. AAPS PharmSciTech. 2012;13:1212–1221.
   PubMed Web of Science ®Google Scholar
• Roger K, Cabane B, Olsson U. Formation of 10−100 nm size-controlled emulsions through a sub-PIT cycle. Langmuir. 2009;26:3860–3867.
   Web of Science ®Google Scholar
• Roger K, Cabane B, Olsson U. Emulsification through surfactant hydration: the PIC process revisited. Langmuir. 2010;27:604–611.
   PubMed Web of Science ®Google Scholar
• Solans C, Solé I. Nano-emulsions: formation by low-energy methods. Curr Opin Colloid Interface Sci. 2012;17:246–254.
   Web of Science ®Google Scholar
• Wennerström H, Balogh J, Olsson U. Interfacial tensions in microemulsions. Colloids Surf A Physicochem Eng Asp. 2006;291:69–77.
   Web of Science ®Google Scholar
• Kong M, Chen XG, Kweon DK, et al. Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydr Polym. 2011;86:837–843.
   Web of Science ®Google Scholar
• Huang Q, Yu H, Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci. 2010;75:R50–R57.
   PubMed Web of Science ®Google Scholar
• Oh DH, Kang JH, Kim DW, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420:412–418.
   PubMed Web of Science ®Google Scholar
• Wilking JN, Mason TG. Irreversible shear-induced vitrification of droplets into elastic nanoemulsions by extreme rupturing. Phys Rev E. 2007;75:041407.
   Web of Science ®Google Scholar
• Singh B, Bandopadhyay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2009;26:427–451.
   Web of Science ®Google Scholar
• Shakeel F, Iqbal M, Ezzeldin E. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self‐nanoemulsifying drug delivery system. J Pharm Pharmacol. 2016;68:772–780.
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Patel DJ, Udhani RA, et al. Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. Sci Pharm. 2011;79:705–727.
   PubMedGoogle Scholar
• Khan AW, Kotta S, Ansari SH, et al. Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv. 2012;9:1305–1317.
   PubMed Web of Science ®Google Scholar
• Chime S, Kenechukwu F, Attama A. Nanoemulsions—advances in formulation, characterization and applications in drug delivery. Ali DS Appl Nanotechnol Drug Delivery Croatia In Tech. 2014;3:77–111.
   Google Scholar
• Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12:1121–1133.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, El-Badry M, et al. Ultra fine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin. J Mol Liq. 2013;180:89–94.
   Web of Science ®Google Scholar
• Larsen AT, Ohlsson AG, Polentarutti B, et al. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation. Eur J Pharm Sci. 2013;48:339–350.
   PubMed Web of Science ®Google Scholar
• Thomas N, Müllertz A, Graf A, et al. Influence of lipid composition and drug load on the in vitro performance of self‐nanoemulsifying drug delivery systems. J Pharm Sci. 2012;101:1721–1731.
   PubMed Web of Science ®Google Scholar
• Bandivadekar M, Pancholi S, Kaul-Ghanekar R, et al. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study. Drug Dev Ind Pharm. 2013;39:696–703.
   PubMed Web of Science ®Google Scholar
• Rane SS, Anderson BD. What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev. 2008;60:638–656.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. 2015;22:522–530.
   PubMed Web of Science ®Google Scholar
• Patel A, Shelat P, Lalwani A. Development and optimization of solid self-nanoemulsifying drug delivery system (S-SNEDDS) using Scheffe’s design for improvement of oral bioavailability of nelfinavir mesylate. Drug Deliv Transl Res. 2014;4:171–186.
   PubMed Web of Science ®Google Scholar
• Bahloul B, Lassoued MA, Seguin J, et al. Self-emulsifying drug delivery system developed by the HLB-RSM approach: characterization by transmission electron microscopy and pharmacokinetic study. Int J Pharm. 2015;487:56–63.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Haq N, Fetih G, et al. Solubility and dissolution enhancement of tadalafil using self-nanoemulsifying drug delivery system. J Oleo Sci. 2014;63:567–576.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Al-Dhfyan A, et al. Double w/o/w nanoemulsion of 5-fluorouracil for self-nanoemulsifying drug delivery system. J Mol Liq. 2014;200:183–190.
   Web of Science ®Google Scholar
• Shahnaz G, Hartl M, Barthelmes J, et al. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design. Eur J Pharm Biopharm. 2011;79:171–180.
   PubMed Web of Science ®Google Scholar
• Abbaspour M, Jalayer N, Makhmalzadeh BS. Development and evaluation of a solid self-nanoemulsifying drug delivery system for loratadin by extrusion-spheronization. Adv Pharm Bull. 2014;4:113.
   PubMedGoogle Scholar
• Wang Z, Sun J, Wang Y, et al. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 2010;383:1–6.
   PubMed Web of Science ®Google Scholar
• Singh SK, Prasad Verma PR, Razdan B. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization. Drug Dev Ind Pharm. 2010;36:933–945.
   PubMed Web of Science ®Google Scholar
• Larsen AT, Sassene P, Müllertz A. In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. Int J Pharm. 2011;417:245–255.
   PubMed Web of Science ®Google Scholar
• Mohsin K, Long MA, Pouton CW. Design of lipid‐based formulations for oral administration of poorly water‐soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 2009;98:3582–3595.
   PubMed Web of Science ®Google Scholar
• Do Thi T, Van Speybroeck M, Barillaro V, et al. Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 2009;38:479–488.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Katare O, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv. 2014;11:479–492.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen C, Zheng J, et al. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability. Biol Pharm Bull. 2011;34:278–286.
   PubMed Web of Science ®Google Scholar
• Wei Y, Ye X, Shang X, et al. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Asp. 2012;396:22–28.
   Web of Science ®Google Scholar
• Sassene PJ, Knopp MM, Hesselkilde JZ, et al. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. J Pharm Sci. 2010;99:4982–4991.
   PubMed Web of Science ®Google Scholar
• Gao P, Akrami A, Alvarez F, et al. Characterization and optimization of AMG 517 supersaturatable self‐emulsifying drug delivery system (S‐SEDDS) for improved oral absorption. J Pharm Sci. 2009;98:516–528.
   PubMed Web of Science ®Google Scholar
• Thomas N, Holm R, Garmer M, et al. Supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. AAPS J. 2013;15:219–227.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3:97–110.
   PubMedGoogle Scholar
• Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility‐limited oral bioavailability? J Pharm Sci. 2009;98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92:2386–2398.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Kiepfer B, Davis A, et al. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm. 2001;221:95–105.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol. Artif Cells Nanomed Biotechnol. 2015;44:1–7.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Alanazi FK, et al. Polymeric solid self-nanoemulsifying drug delivery system of glibenclamide using coffee husk as a low cost biosorbent. Powder Technol. 2014;256:352–360.
   Web of Science ®Google Scholar
• Kamel AO, Mahmoud AA. Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system. J Biomed Nanotechnol. 2013;9:26–39.
   PubMed Web of Science ®Google Scholar
• Seo YG, Kim DH, Ramasamy T, et al. Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm. 2013;452:412–420.
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Bandari S, Jukanti R, et al. Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol. 2012;221:375–382.
   Web of Science ®Google Scholar
• Tang B, Cheng G, Gu J-C, et al. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13:606–612.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S. Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res. 2014;31:923–945.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Williams HD, Nguyen T-H, et al. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier. Mol Pharm. 2012;9:2750–2760.
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, et al. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv. 2015;22:765–784.
   PubMed Web of Science ®Google Scholar
• Song WH, Park JH, Yeom DW, et al. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation. Arch Pharm Res. 2013;36:69–78.
   PubMed Web of Science ®Google Scholar
• Hassan TH, Metz H, Mäder K. Novel semisolid SNEDDS based on PEG-30-dipolyhydroxystearate: development and characterization. Int J Pharm. 2014;477:506–518.
   PubMed Web of Science ®Google Scholar
• Parmar K, Patel J, Sheth N. Self nano-emulsifying drug delivery system for Embelin: design, characterization and in-vitro studies. Asian J Pharm Sci. 2015;10:396–404.
   Web of Science ®Google Scholar
• Abdelbary G, Amin M, Salah S. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation. Pharm Dev Technol. 2013;18:1294–1304.
   PubMed Web of Science ®Google Scholar
• Mohd AB, Sanka K, Bandi S, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits. Drug Deliv. 2015;22:499–508.
   PubMed Web of Science ®Google Scholar
• Agrawal AG, Kumar A, Gide PS. Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent. Drug Dev Ind Pharm. 2015;41:594–604.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Alanazi FK, et al. Surface-adsorbed reverse micelle-loaded solid self-nanoemulsifying drug delivery system of talinolol. Pharm Dev Technol. 2014;21:1–9.
   PubMed Web of Science ®Google Scholar
• Kang JH, Oh DH, Oh Y-K, et al. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm. 2012;80:289–297.
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, et al. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech. 2012;13:1416–1427.
   PubMed Web of Science ®Google Scholar
• Reddy MS, Rudra R, Haq MF. Formulation and evaluation of solid self nano emulsifying drug delivery system (S-SNEDDS) of ritonavir drug. Indo Am J Pharm Res. 2015;5:2910–2924.
   Google Scholar
• Fagir W, Hathout RM, Sammour OA, et al. Self-microemulsifying systems of Finasteride with enhanced oral bioavailability: multivariate statistical evaluation, characterization, spray-drying and in vivo studies in human volunteers. Nanomedicine. 2015;10:3373–3389.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yi Y, Qi J, et al. Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogs. Int J Pharm. 2013;452:233–240.
   PubMed Web of Science ®Google Scholar
• Guan P, Lu Y, Qi J, et al. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomed. 2011;6:e974.
   Web of Science ®Google Scholar
• Wang Y, Sun J, Zhang T, et al. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2011;37:1225–1230.
   PubMed Web of Science ®Google Scholar
• Jyothi BJ, Sreelakshmi K. Design and evaluation of self-nanoemulsifying drug delivery system of flutamide. J Young Pharm. 2011;3:4–8.
   PubMedGoogle Scholar
• Lu Y, Qi J, Wu W. Absorption, disposition and pharmacokinetics of nanoemulsions. Curr Drug Metab. 2012;13:396–417.
   PubMed Web of Science ®Google Scholar
• Miao Y, Chen G, Ren L, et al. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect. Drug Deliv. 2014;21:1–10.
   Web of Science ®Google Scholar
• Wei L, Li J, Guo L, et al. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev Ind Pharm. 2007;33:990–998.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm. 2006;315:110–121.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang R, Wu J, et al. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Int J Pharm. 2012;427:337–344.
   PubMed Web of Science ®Google Scholar
• Park M-J, Balakrishnan P, Yang S-G. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm. 2013;441:757–764.
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, et al. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur J Pharm Sci. 2008;34:274–280.
   PubMed Web of Science ®Google Scholar
• Patil PR, Biradar SV, Paradkar AR. Extended release felodipine self-nanoemulsifying system. AAPS PharmSciTech. 2009;10:515–523.
   PubMed Web of Science ®Google Scholar
• Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011;153:106–116.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557–570.
   PubMed Web of Science ®Google Scholar
• Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol Biosci. 2010;10:1473–1483.
   PubMed Web of Science ®Google Scholar
• Sakloetsakun D, Dünnhaupt S, Barthelmes J, et al. Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. Int J Biol Macromol. 2013;61:363–372.
   PubMed Web of Science ®Google Scholar
• Dünnhaupt S, Kammona O, Waldner C, et al. Nano-carrier systems: strategies to overcome the mucus gel barrier. Eur J Pharm Biopharm. 2015;96:447–453.
   PubMed Web of Science ®Google Scholar
• Friedl H, Dünnhaupt S, Hintzen F, et al. Development and evaluation of a novel mucus diffusion test system approved by self‐nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102:4406–4413.
   PubMed Web of Science ®Google Scholar
• Barthelmes J, Dünnhaupt S, Hombach J, et al. Thiomer nanoparticles: stabilization via covalent cross-linking. Drug Deliv. 2011;18:613–619.
   PubMed Web of Science ®Google Scholar
• Silva CO, Reis CP. Drug nanocarriers based on biomacromolecules: how far we’ve come? In: Navani NK, Sinha S, Govil JN, editors. Nanotechnology Vol. 11: Biomaterials. New Delhi: Studium Press; 2014. p. 127–146
   Google Scholar
• Dimitrov DS. Therapeutic proteins. Ther Proteins Methods Protoc. 2012;899:1–26.
   Google Scholar
• Kayser O, Warzecha H. Pharmaceutical biotechnology: drug discovery and clinical applications. Hoboken (NJ): John Wiley & Sons; 2012.
   Google Scholar
• Ginn SL, Alexander IE, Edelstein ML, et al. Gene therapy clinical trials worldwide to 2012–an update. J Gene Med. 2013;15:65–77.
   PubMed Web of Science ®Google Scholar
• Hauptstein S, Prüfert F, Bernkop-Schnürch A. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm. 2015;487:25–31.
   PubMed Web of Science ®Google Scholar
• Rao SVR, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm. 2008;362:2–9.
   PubMed Web of Science ®Google Scholar
• Hintzen F, Perera G, Hauptstein S, et al. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm. 2014;472:20–26.
   PubMed Web of Science ®Google Scholar
• Karamanidou T, Karidi K, Bourganis V, et al. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm. 2015;97:223–229.
   PubMed Web of Science ®Google Scholar
• Qi X, Wang L, Zhu J, et al. Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm. 2011;409:245–251.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang S, Wang X, et al. Preparation and evaluation of nattokinase-loaded self-double-emulsifying drug delivery system. Asian J Pharm Sci. 2015;10:386–395.
   Web of Science ®Google Scholar
• Venkata Siddhartha T, Senthil V, Sai Kishan I, et al. Design and development of oral nanoparticulated insulin in multiple emulsion. Curr Drug Deliv. 2014;11:472–485.
   PubMed Web of Science ®Google Scholar
• Shima M, Tanaka M, Fujii T, et al. Oral administration of insulin included in fine W/O/W emulsions to rats. Food Hydrocoll. 2006;20:523–531.
   Web of Science ®Google Scholar
• Allam AN, Komeil IA, Fouda MA, et al. Preparation, characterization and in vivo evaluation of curcumin self-nano phospholipid dispersion as an approach to enhance oral bioavailability. Int J Pharm. 2015;489:117–123.
   PubMed Web of Science ®Google Scholar
• Taha EI, Al-Suwayeh SA, Anwer MK. Preparation, in vitro and in vivo evaluation of solid-state self-nanoemulsifying drug delivery system (SNEDDS) of vitamin A acetate. J Drug Target. 2009;17:468–473.
   PubMed Web of Science ®Google Scholar
• Shanmugam S, Baskaran R, Balakrishnan P, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm. 2011;79:250–257.
   PubMed Web of Science ®Google Scholar
• Rao SVR, Agarwal P, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study. Int J Pharm. 2008;362:10–15.
   PubMed Web of Science ®Google Scholar
• Rao SVR, Yajurvedi K, Shao J. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study. Int J Pharm. 2008;362:16–19.
   PubMed Web of Science ®Google Scholar
• Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010;62:28–41.
   PubMed Web of Science ®Google Scholar
• Hallouard F, Anton N, Choquet P, et al. Iodinated blood pool contrast media for preclinical X-ray imaging applications–a review. Biomaterials. 2010;31:6249–6268.
   PubMed Web of Science ®Google Scholar
• Hörmann K, Zimmer A. Drug delivery and drug targeting with parenteral lipid nanoemulsions—A review. J Control Release. 2016;223:85–98.
   PubMed Web of Science ®Google Scholar
• Nikonenko B, Reddy VM, Bogatcheva E, et al. Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014;58:587–589.
   PubMed Web of Science ®Google Scholar
• Hua S, Marks E, Schneider JJ, et al. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11:1117–1132.
   PubMed Web of Science ®Google Scholar
• Laine A-L, Gravier J, Henry M, et al. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring. J Control Release. 2014;188:1–8.
   PubMed Web of Science ®Google Scholar
• Feeney OM, Williams HD, Pouton CW, et al. ‘Stealth’lipid-based formulations: poly (ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug. J Control Release. 2014;192:219–227.
   PubMed Web of Science ®Google Scholar
• Hunter AC, Elsom J, Wibroe PP, et al. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine. 2012;8:S5–S20.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Singh K. Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs. Die Pharmazie Int J Pharm Sci. 2011;66:264–271.
   Google Scholar
• Das Neves J, Amiji MM, Bahia MF, et al. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. Adv Drug Deliv Rev. 2010;62:458–477.
   PubMed Web of Science ®Google Scholar
• Komohara Y, Fujiwara Y, Ohnishi K, et al. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev. 2015;99:180–185.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136–151.
   PubMed Web of Science ®Google Scholar
• Kollipara S, Gandhi RK. Pharmacokinetic aspects and in vitro–in vivo correlation potential for lipid-based formulations. Acta Pharm Sin B. 2014;4:333–349.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Pouton CW, Cuine JF, et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673–691.
   PubMed Web of Science ®Google Scholar
• Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15:958–965.
   PubMed Web of Science ®Google Scholar
• Dai WG, Dong LC, Shi X, et al. Evaluation of drug precipitation of solubility‐enhancing liquid formulations using milligram quantities of a new molecular entity (NME). J Pharm Sci. 2007;96:2957–2969.
   PubMed Web of Science ®Google Scholar
• Donato EM, Martins LA, Fröehlich PE, et al. Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data. J Pharm Biomed Anal. 2008;47:547–552.
   PubMed Web of Science ®Google Scholar
• Sek L, Boyd BJ, Charman WN, et al. Examination of the impact of a range of Pluronic surfactants on the in‐vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone. J Pharm Pharmacol. 2006;58:809–820.
   PubMed Web of Science ®Google Scholar
• Bahloul B, Lassoued MA, Sfar S. A novel approach for the development and optimization of self emulsifying drug delivery system using HLB and response surface methodology: application to fenofibrate encapsulation. Int J Pharm. 2014;466:341–348.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release. 2008;129:1–10.
   PubMed Web of Science ®Google Scholar
• Sagitani H. Making homogeneous and fine droplet O/W emulsions using nonionic surfactants. J Am Oil Chem Soc. 1981;58:738–743.
   Web of Science ®Google Scholar
• Malcolmson C, Satra C, Kantaria S, et al. Effect of oil on the level of solubilization of testosterone propionate into nonionic oil‐in‐water microemulsions. J Pharm Sci. 1998;87:109–116.
   PubMed Web of Science ®Google Scholar
• Warisnoicharoen W, Lansley A, Lawrence M. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm. 2000;198:7–27.
   PubMed Web of Science ®Google Scholar
• Wang L, Dong J, Chen J, et al. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci. 2009;330:443–448.
   PubMed Web of Science ®Google Scholar
• Gullapalli RP, Sheth BB. Influence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsions. Eur J Pharm Biopharm. 1999;48:233–238.
   PubMed Web of Science ®Google Scholar